Abstract: Biomarkers for pre-Diabetes, Diabetes and/or a Diabetes related conditions, and methods of their use, including the biomarkers in Tables 1 and 2 such as peroxiredoxin-2, complement C1q subcomponent subunit B, sulfhydryl oxidase 1 and apolipoprotein A-IV.
Type:
Grant
Filed:
May 14, 2014
Date of Patent:
September 29, 2015
Assignees:
Proteomics International Pty Ltd, The University of Western Australia
Inventors:
Thomas Stoll, Scott Bringans, Kaye Winfield, Tammy Casey, Wendy Davis, Kirsten Peters, Timothy Davis, Richard Lipscombe
Abstract: A graphene nano-sensor with a suspended graphene flake electrically connected to metal electrodes. The graphene nano-sensor is capable of detecting single molecules in an atmosphere through a change in electrical conductance through the graphene flake.
Abstract: A method, wireless device and computer program product for expanding the coverage of a cellular network. A wireless device (e.g., cellular telephone) is able to communicate with a base station in a cell of the cellular network over a non-cellular interface via another wireless device in the cell through the use of multi-hopping. A wireless device may request permission to communicate with the base station over a non-cellular interface via hopping off another wireless device when its signal strength is below a threshold. Alternatively, a wireless device may receive a request to communicate with the base station over a non-cellular interface via hopping off the wireless device that sent the request when that wireless device has excess capacity in its bandwidth with the base station. By enabling wireless devices to communicate with a base station in such a manner, the effective coverage area of the cellular network is expanded and the effective capacity of the cellular network is improved.
Type:
Grant
Filed:
June 3, 2011
Date of Patent:
September 29, 2015
Assignee:
Board of Regents, The University of Texas System
Inventors:
Vidur Bhargava, Sriram Vishwanath, Jubin Jose
Abstract: An improved reference current generator is provided. A voltage difference generator generates two voltages that are separated by a relatively small electrical potential. The two closely separated voltages are applied across a resistive element with relatively large impedance value resulting in a small and stable reference current. The result is a power efficient, temperature compensated reference current generator.
Type:
Grant
Filed:
May 16, 2012
Date of Patent:
September 29, 2015
Assignee:
The Regents Of The University of Michigan
Inventors:
Scott Hanson, Dennis Sylvester, David Blaauw
Abstract: A sensor for detecting the presence of unsaturated compounds, the sensor comprising: a semiconductor material doped with a metal halide in electrical connection with a monitoring device.
Type:
Grant
Filed:
May 29, 2012
Date of Patent:
September 29, 2015
Assignee:
The University of Toledo
Inventors:
Abdul-Majeed Azad, Desikan Sundararajan, Robert Howard Kinner
Abstract: The present invention relates to methods, systems, and compositions for treating and preventing cancer in a subject with the combination of radiation therapy and antigen presenting cells that have been exposed cancer stem cells or a portion thereof. In certain embodiments, the antigen presenting cells are dendritic cells that have been pulsed with ALDHhigh cancer stem cells.
Type:
Application
Filed:
October 24, 2013
Publication date:
September 24, 2015
Applicant:
The Regents of The University of Michigan
Abstract: Methods of forming at least one nanochannel include: (a) providing a substrate having a thick single or a thick multi-layer overlayer; (b) milling at least one channel through the overlayer into the substrate; then (c) removing the overlayer; and (d) forming at least one nanochannel in the substrate having an average width and depth dimension that is less than about 10 nm in response to the milling and removing steps.
Type:
Grant
Filed:
September 19, 2011
Date of Patent:
September 22, 2015
Assignee:
The University of North Carolina at Chapel Hill
Inventors:
John Michael Ramsey, Laurent Menard, Valeri Gorbounov
Abstract: An FPGA has a number of CLBs, each CLB having a number of CABs (10, 110, 210, 310, 410). Each CAB (10, 110, 210, 310, 410) comprises: a number of configurable transistors (20, 120, 220, 320, 420) each comprising one or more useable transistors M and a number of switching transistors; and, configuration circuitry comprising a number of switching transistors. The ratio of switching transistors to useable transistors for each CAB is less than 26:1. A method of configuring such an FPGA comprises optimizing each configurable transistor.
Type:
Grant
Filed:
November 2, 2012
Date of Patent:
September 22, 2015
Assignee:
The University of York
Inventors:
Martin Trefzer, Andrew Tyrrell, James Walker
Abstract: The present invention pertains to a protein having the characteristics of a serine protease having an amino acid sequence according to SEQ ID NO 2 for use as a medicament. The invention also pertains to this protein for use in a vaccine to protect an animal against an infection with a micro organism that secretes said protein, and to the corresponding antibodies directed against the protein.
Type:
Grant
Filed:
April 20, 2012
Date of Patent:
September 22, 2015
Assignee:
The University Court of the University of Aberdeen
Inventors:
Pieter van West, Christopher John Secombes, Victoria Louise Anderson, Kirsty Louise Minor
Abstract: The present invention provides methods for stimulating or enhancing the conversion of coal to methane. The methods of the current invention subject coal to an oxidation step, for example ozonolysis, thereby converting at least a portion of the coal to partially-oxidized and water-soluble forms of organic matter. Subsequent contact of the oxidized coal components with a suitable inoculum containing a methanogenic microbial community produces methane.
Type:
Grant
Filed:
April 9, 2012
Date of Patent:
September 22, 2015
Assignee:
The Board of Regents of The University of Oklahoma
Inventors:
Joseph Suflita, Mark Nanny, Margarita Mendivelso Castro, Jan Sunner
Abstract: This invention relates to a system that adaptively compensates for subject motion in real-time in an imaging system. An object orientation marker (30), preferably a retro-grate reflector (RGR), is placed on the head or other body organ of interest of a patient (P) during a scan, such as an MRI scan. The marker (30) makes it possible to measure the six degrees of freedom (x, y, and z-translations, and pitch, yaw, and roll), or “pose”, required to track motion of the organ of interest. A detector, preferably a camera (40), observes the marker (30) and continuously extracts its pose. The pose from the camera (40) is sent to the scanner (120) via an RGR processing computer (50) and a scanner control and processing computer (100), allowing for continuous correction of scan planes and position (in real-time) for motion of the patient (P).
Type:
Grant
Filed:
April 28, 2015
Date of Patent:
September 22, 2015
Assignees:
The Queen's Medical Center, The University of Hawaii, The Medical College of Wisconsin, Inc., UWM Research Foundation, Inc.
Inventors:
Thomas Michael Ernst, Thomas Edmund Prieto, Brian Stewart Randall Armstrong
Abstract: The invention is directed to long lasting crosslinked water-soluble swellable polymers, methods for making same, and their uses. More particularly, the invention relates to a composition comprising expandable polymeric particles having cationic sites as well as labile crosslinkers and stable crosslinkers, said particle mixed with a fluid. A particularly important use is as an injection fluid in petroleum production, where the expandable polymeric particles are injected into a target zones in the reservoirs and when the heat and/or a suitable pH in the reservoir cause degradation of the labile crosslinker and when the particle expands, the cationic sites in the polymer adsorb to negative sites of the rock in the formation, thus diverting water to lower permeability regions and improving oil recovery. However, many other uses are possible.
Type:
Grant
Filed:
February 18, 2014
Date of Patent:
September 22, 2015
Assignees:
ConocoPhillips Company, The University of Kansas
Inventors:
Ahmad Moradi-Araghi, James H. Hedges, David R. Zornes, Riley B. Needham, Huili Guan, Jenn-Tai Liang, Cory Berkland, James P. Johnson, Min Cheng, Faye Lynn Scully
Abstract: The present invention provides superior compositions and methods for the delivery of therapeutic agents to cells. In particular, these include novel lipids and nucleic acid-lipid particles that provide efficient encapsulation of nucleic acids and efficient delivery of the encapsulated nucleic acid to cells in vivo. The compositions of the present invention are highly potent, thereby allowing effective knock-down of specific target proteins at relatively low doses. In addition, the compositions and methods of the present invention are less toxic and provide a greater therapeutic index compared to compositions and methods previously known in the art.
Type:
Grant
Filed:
October 9, 2009
Date of Patent:
September 22, 2015
Assignees:
Tekmira Pharmaceuticals Corporation, The University of British Columbia
Inventors:
Michael J. Hope, Sean C. Semple, Jianxin Chen, Thomas D. Madden, Pieter R. Cullis, Marco A. Ciufolini, Barbara Low Shoud Mui
Abstract: Methods are described for construction of long synthetic arrays of DNA repeats, such as alphoid repeats or other repeat sequences. The methods include concatamerization of DNA into short repeats (for instance using rolling circle amplification or directional in vitro ligation), followed by assembling the short repeats into long arrays by homologous recombination during transformation into microbe cells. These methods can be described generally as Recombinational Amplification of Repeats (RAR). The long arrays are engineered centromere-like regions that allow one to construct mammalian artificial chromosomes with a predefined centromeric region structure. Artificial chromosomes, including human artificial chromosomes with a regulated centromere, and methods of their use are also provided.
Type:
Grant
Filed:
April 7, 2006
Date of Patent:
September 22, 2015
Assignees:
The United States of America as Represented by the Government of the Department of Health and Human Services, The University Court of the University of Edinburgh
Inventors:
Vladimir L. Larionov, William C. Earnshaw, Reto Gassman, Stefanie Kandels-Lewis, Hiroshi Masumoto, Megumi Nakano, Vladimir Noskov, Natalay Y. Kouprina, Carl J. Barrett, Stefano Cardinale
Abstract: Cannabinoid derivatives according to formula (I) are disclosed wherein, X, Y, R1, R2, and W can have the definitions provided herein. Without limitation, use of such compounds, their salts or pro-drug, or compositions containing the compounds, salts, or pro-drug, to modify the activity of CB1 and CB2 receptors and treat conditions mediated by these receptors.
Type:
Grant
Filed:
February 10, 2011
Date of Patent:
September 22, 2015
Assignee:
The University of Tennessee Research Foundation
Inventors:
Bob M. Moore, II, Himanshu Bhattacharjee, Suni Mustafa
Abstract: Shear force and pressure on a structure are simultaneously monitored using signals received from antennas on the structure. The shear force on the structure is monitored using a signal received from a patch antenna on the structure, and the pressure on the structure is monitored using a signal received from a loop antenna on the structure.
Type:
Grant
Filed:
February 13, 2014
Date of Patent:
September 22, 2015
Assignee:
Board of Regents, The University of Texas System
Abstract: An apparatus for analyzing free flight of a body including an inertial measurement unit having at least one accelerometer continuously measuring three orthogonal axes of acceleration and outputting data representative thereof and a processing unit operably receiving the data and determining three components of an angular velocity of the body during free flight.
Type:
Grant
Filed:
September 20, 2011
Date of Patent:
September 22, 2015
Assignee:
The Regents of The University of Michigan
Abstract: The compositions of the invention are novel benzothiazol-based pyridinium compounds with potent acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory activities. Such compositions can be used, for example, to treat Alzheimer's Disease and other neurodegenerative disorders. The compounds of the invention can also be used to prevent or treat the neurotoxic effects of nerve agents (e.g., sarin gas or insecticides).
Abstract: Aspects of the present disclosure relate generally to preparing models of three-dimensional structures. In particular, a model of a three-dimensional structure constructed of porous geometries is prepared. A component file including a porous CAD volume having a predefined portion of a boundary. A space including the porous CAD volume is populated with unit cells overlapping the predefined portion of the boundary. The unit cells are populated with porous geometries having a plurality of struts having nodes on each end. At least a first strut overlaps the predefined portion of the boundary and has a length, a first node outside the porous CAD volume, and a second node inside the porous CAD volume. All struts entirely outside the porous CAD volume are removed. After removal of the struts entirely outside the porous CAD volume, each of the remaining struts is connected to a node at each end thereof.
Type:
Grant
Filed:
April 6, 2012
Date of Patent:
September 15, 2015
Assignees:
Howmedica Osteonics Corp., The University Of Liverpool
Inventors:
Eric Jones, Christopher J. Sutcliffe, Joe Robinson, Dan Jones, Lewis Mullen